Join the Oncology Voice Network. Join for Free
Important TIPS for KOL Mapping
KOL mapping key opinion leaders cross-functional coordination outreach methods Medical Science Liaison

Important TIPS for KOL Mapping


Share This Article


Summary

In this episode, Keely Dahl shares her expertise on KOL mapping, offering valuable insights into identifying and ranking key opinion leaders. She outlines the importance of cross-functional coordination in engaging with KOLs and provides strategies for acquiring meetings and optimizing contact lists. Keely discusses effective outreach methods, including email and phone communication, and emphasizes the significance of networking at conferences. The episode concludes with best practices for email communication and essential advice for MSLs aiming to enhance their KOL mapping skills.

Keely Dahl, Sr Medical Science Liaison at Aurinia Pharmaceuticals shares important tips for KOL mapping based on her real life experience

Keely shares…

πŸ‘‰ What is KOL Mapping and how to build your list

πŸ‘‰ Best ways to coordinate with cross functional partners

πŸ‘‰ Unique ways to engage with KOLs and gain better access

πŸ‘‰ How to maintain and prioritize your list

πŸ‘‰ Advice for closing out the year on a strong note

Click for Source
KOL mapping, key opinion leaders, cross-functional coordination, outreach methods, Medical Science Liaison

Related Topics

Meet Our Innovation Partners

Loading partners...

You May Also Like

Podcast
Social Media Listening Evolved
Partner Avatar MSL Talk: Tom Caravela, Conor McGladrigan, Kevin Peterson

Social Media Listening Evolved

Podcast
Over-Negotiation-How to Botch a Job Offer
Partner Avatar MSL Talk: Tom Caravela

Over-Negotiation-How to Botch a Job Offer

Article
Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?
OVN Avatar Michael Z. Liao, Dan Lu, Matts KΓ₯gedal, Dale Miles, Divya Samineni, Stephanie N. Liu, Chunze Li

Model-Informed Therapeutic Dose Optimization Strategies for Antibody-Drug Conjugates in Oncology: What Can We Learn From US Food and Drug Administration-Approved Antibody-Drug Conjugates?

Podcast
MSL Career Options: The transition from Field Medical to Medical Director
Partner Avatar MSL Talk: Tom Caravela, Josh Corriveau

MSL Career Options: The transition from Field Medical to Medical Director

Article
Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials
OVN Avatar Shubham Sharma, J Connor Wells, Wilma M Hopman, Joseph C Del Paggio, Bishal Gyawali, Nazik Hammad, Annette E Hay, Christopher M Booth

Cancer, Clinical Trials, and Canada: Our Contribution to Worldwide Randomized Controlled Trials

Article
CheckMate-067: Raising the Bar for the Next Decade in Oncology
OVN Avatar Sarah A. Weiss, MD, and Harriet Kluger, MD

CheckMate-067: Raising the Bar for the Next Decade in Oncology

Explore OVN